Intensive Plasma IgG Removal Therapy for Severe Thrombotic Thrombocytopenic Purpura

We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Fujimura Y, Matsumoto M, Yagi H, Yoshioka A, Matsui T, Titani K. Von-Willebrand factor-cleaving protease and Upshaw-Schulman syndrome.Int J Hematol. 2002;75:25–34.

    Article  PubMed  CAS  Google Scholar 

  2. 2.

    Furlan M, Robles R, Galbusera M, et al. Von Willebrand factor- cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.N Engl J Med. 1998;339: 1578–1584.

    Article  PubMed  CAS  Google Scholar 

  3. 3.

    Tsai H-M, Lian EC-Y. Antibodies to von Willebrand factor- cleaving protease in acute thrombotic thrombocytopenic purpura.N Engl J Med. 1998;339:1585–1594.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  4. 4.

    Bondarenko N, Brecher ME. Members of the US TTP Apheresis Study Group. United States thrombotic thrombocytopenic purpura apheresis study group (US TTP ASG): multicenter survey and retrospective analysis of current efficacy of therapeutic plasma exchange.J Clin Apheresis. 1998;13:133–141.

    Article  Google Scholar 

  5. 5.

    Rund D, Schaap T, Gillis S. Intensive plasmapheresis for severe thrombotic thrombocytopenic purpura: a long-term clinical outcome.J Clin Apheresis. 1997;12:194–195.

    Article  PubMed  CAS  Google Scholar 

  6. 6.

    Tsai H-M, Rice L, Sarode R, Chow T, Moake JL. Antibody inhibitors to von Willebrand factor metalloproteinase and increased binding of von Willebrand factor to platelets in ticlopi- dine-associated thrombotic thrombocytopenic purpura.Ann Intern Med. 2000;132:794–799.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  7. 7.

    Mori Y, Wada H, Gabazza EC, et al. Predicting response to plasma exchange in patients with thrombotic thrombocytopenic purpura with measurement of vWF-cleaving protease activity.Transfusion. 2002;42:572–580.

    Article  PubMed  CAS  Google Scholar 

  8. 8.

    Kinoshita S, Yoshioka A, Park YD, et al. Upshaw-Schulman syndrome revisited: a concept of congenital thrombotic thrombocy- topenic purpura.Int J Hematol. 2001;74:101–108.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding authors

Correspondence to Saori Yasuzawa Amano or Masafumi Inoue or Yataro Yoshida or Hideo Yagi or Hiromichi Ishizashi or Masanori Matsumoto or Yoshihiro Fujimura or Akira Yoshioka.

About this article

Cite this article

Amano, S.Y., Inoue, M., Yoshida, Y. et al. Intensive Plasma IgG Removal Therapy for Severe Thrombotic Thrombocytopenic Purpura. Int J Hematol 76, 474–476 (2002). https://doi.org/10.1007/BF02982815

Download citation

Keywords

  • Thrombotic Thrombocytopenic Purpura
  • Therapeutic Plasma Exchange
  • Thrombotic Thrombocytopenic Purpura Patient
  • Topenic Purpura
  • Daily Plasma Exchange